timolol has been researched along with Hyperglycemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okatan, EN; Tuncay, E; Turan, B; Vassort, G | 1 |
| Can, B; Cicek, FA; Toy, A; Tuncay, E; Turan, B | 1 |
| Turan, B | 1 |
1 review(s) available for timolol and Hyperglycemia
| Article | Year |
|---|---|
A Comparative Summary on Antioxidant-like Actions of Timolol with Other Antioxidants in Diabetic Cardiomyopathy.
Topics: Animals; Antioxidants; Cardiotonic Agents; Diabetic Cardiomyopathies; Humans; Hyperglycemia; Myocardium; Receptors, Adrenergic, beta; Timolol | 2016 |
2 other study(ies) available for timolol and Hyperglycemia
| Article | Year |
|---|---|
ß-blocker timolol prevents arrhythmogenic Ca²⁺ release and normalizes Ca²⁺ and Zn²⁺ dyshomeostasis in hyperglycemic rat heart.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Antioxidants; Calcium; Calcium-Binding Proteins; Diabetes Mellitus, Experimental; Heart; Hyperglycemia; Intracellular Space; Male; Myocardium; Myocytes, Cardiac; Phosphorylation; Rats; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Calcium Exchanger; Timolol; Zinc | 2013 |
Beta-blocker timolol alleviates hyperglycemia-induced cardiac damage via inhibition of endoplasmic reticulum stress.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Disease Models, Animal; Endoplasmic Reticulum Stress; Heart Diseases; Hyperglycemia; Male; Oxidative Stress; Rats; Rats, Wistar; Timolol | 2014 |